Home›Trial›NCT06855498
🔬NCT06855498Phase 3RECRUITING

Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

Study Summary

Rollover study for participants from predetermined, Incyte-sponsored parent clinical trials of povorcitinib.

Conditions
Hidradenitis Suppurativa (HS)
Interventions / Drugs
povorcitinib
View on ClinicalTrials.gov ↗
Sponsor
INCY
Incyte Corporation
Oncology
C60/100
Study Details
Enrollment600 participants
Primary Completion—
Lead SponsorIncyte Corporation
Data Retrieved2026-04-11 02:55:29.647221+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.